Safety and Efficacy Study of TNX-102 SL in Participants With PTSD

NCT05372887 · clinicaltrials.gov ↗
PHASE2
Phase
WITHDRAWN
Status
INDUSTRY
Sponsor class

Stopped The study was stopped due to business reasons.

Conditions

Interventions

Sponsor

Tonix Pharmaceuticals, Inc.